Inactive Instrument
Precision Therapeutics Inc Share Price Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 7.22Cr 6.31Cr 5.84Cr 5.36Cr 10Cr 695.79Cr 10Cr 70Cr 27Cr 339.78Cr 27Cr 27Cr 1.17TCr | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 6.31Cr 5.51Cr 5.1Cr 4.68Cr 8.86Cr 607.87Cr 9.01Cr 61Cr 24Cr 296.84Cr 24Cr 23Cr 1.02TCr | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
93.75% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 7.22Cr | ||
| -1.07% | -1.27% | +0.95% | +6.28% | 5.03TCr | ||
| -3.56% | -6.93% | +363.24% | +568.49% | 3.92TCr | ||
| +1.57% | +0.54% | +32.44% | -5.09% | 3.45TCr | ||
| +1.83% | +4.91% | +13.81% | +60.54% | 3.46TCr | ||
| +0.06% | -0.57% | +3.35% | +27.42% | 2.7TCr | ||
| -2.63% | -4.66% | - | - | 1.67TCr | ||
| +1.23% | -0.02% | +70.06% | +116.45% | 1.51TCr | ||
| +0.29% | +1.02% | +14.95% | +18.32% | 1.39TCr | ||
| -1.15% | +0.52% | +17.78% | -30.77% | 1.32TCr | ||
| Average | -1.14% | +0.81% | +64.57% | +95.20% | 2.72TCr | |
| Weighted average by Cap. | -0.54% | +0.70% | +76.71% | +117.94% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.24L 14.19L 13.13L 12.05L 22.8L 16Cr 23.19L 1.57Cr 61.5L 7.64Cr 60.98L 59.64L 26Cr | 1L 1L 1L 92.93T 2L 1.21Cr 2L 12.08L 5L 58.95L 5L 5L 2.04Cr |
| Net income | -1.27Cr -1.11Cr -1.02Cr -93.94L -1.78Cr -122.03Cr -1.81Cr -12Cr -4.8Cr -60Cr -4.76Cr -4.65Cr -205.74Cr | -23Cr -20Cr -19Cr -17Cr -33Cr -2.25TCr -33Cr -224.71Cr -88Cr -1.1TCr -88Cr -86Cr -3.79TCr |
| Net Debt | 13.96L 12.21L 11.29L 10.36L 19.6L 13Cr 19.94L 1.35Cr 52.88L 6.57Cr 52.44L 51.28L 23Cr | -91.25L -79.76L -73.76L -67.68L -1.28Cr -88Cr -1.3Cr -8.8Cr -3.46Cr -43Cr -3.43Cr -3.35Cr -148.23Cr |
Employees
-

















